Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China
· Delayed Price · Currency is CNY 31.02
+0.60 (1.97%)
At close: Mar 10, 2026
SHE:002940 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,083 | 2,632 | 4,377 | 3,684 | 3,486 | 3,968 | Upgrade
|
| Market Cap Growth | 121.53% | -39.86% | 18.80% | 5.68% | -12.16% | 47.37% | Upgrade
|
| Enterprise Value | 5,994 | 2,582 | 4,255 | 3,430 | 2,877 | 3,421 | Upgrade
|
| Last Close Price | 31.02 | 13.11 | 21.30 | 18.11 | 16.64 | 18.68 | Upgrade
|
| PE Ratio | 57.52 | 32.77 | 31.63 | 28.94 | 29.09 | 24.24 | Upgrade
|
| PS Ratio | 4.20 | 1.74 | 2.70 | 2.35 | 2.53 | 3.08 | Upgrade
|
| PB Ratio | 3.33 | 1.46 | 2.39 | 2.24 | 2.36 | 2.88 | Upgrade
|
| P/TBV Ratio | 5.27 | 2.43 | 3.86 | 2.56 | 2.73 | 3.10 | Upgrade
|
| P/FCF Ratio | 41.97 | 16.54 | 28.80 | 31.78 | 31.59 | 36.86 | Upgrade
|
| P/OCF Ratio | 31.80 | 10.38 | 15.81 | 19.94 | 17.64 | 19.98 | Upgrade
|
| EV/Sales Ratio | 4.14 | 1.71 | 2.63 | 2.19 | 2.08 | 2.65 | Upgrade
|
| EV/EBITDA Ratio | 29.03 | 12.58 | 17.65 | 16.91 | 14.56 | 16.80 | Upgrade
|
| EV/EBIT Ratio | 53.49 | 21.81 | 26.00 | 24.19 | 19.02 | 21.12 | Upgrade
|
| EV/FCF Ratio | 41.35 | 16.23 | 28.00 | 29.59 | 26.07 | 31.78 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.27 | 0.32 | 0.21 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 2.27 | 2.37 | 2.43 | 1.71 | 0.01 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 3.23 | 3.06 | 3.88 | 2.99 | 0.02 | 0.11 | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.14 | -0.15 | -0.28 | -0.51 | -0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.56 | -1.20 | -1.16 | -2.26 | -3.78 | -4.14 | Upgrade
|
| Net Debt / FCF Ratio | -2.22 | -1.55 | -1.84 | -3.95 | -6.77 | -7.82 | Upgrade
|
| Asset Turnover | 0.48 | 0.51 | 0.58 | 0.67 | 0.69 | 0.78 | Upgrade
|
| Inventory Turnover | 1.89 | 2.06 | 2.66 | 2.28 | 1.74 | 1.60 | Upgrade
|
| Quick Ratio | 1.27 | 1.16 | 1.55 | 1.40 | 1.79 | 2.06 | Upgrade
|
| Current Ratio | 1.90 | 1.78 | 2.13 | 1.84 | 2.31 | 2.56 | Upgrade
|
| Return on Equity (ROE) | 8.06% | 8.37% | 10.53% | 8.46% | 9.91% | 15.14% | Upgrade
|
| Return on Assets (ROA) | 2.33% | 2.47% | 3.64% | 3.79% | 4.70% | 6.09% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.57% | 7.31% | 10.55% | 13.29% | 19.59% | 30.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.20% | 5.60% | 7.20% | 7.80% | 10.20% | 11.60% | Upgrade
|
| Earnings Yield | 1.78% | 3.05% | 3.16% | 3.46% | 3.44% | 4.13% | Upgrade
|
| FCF Yield | 2.38% | 6.05% | 3.47% | 3.15% | 3.16% | 2.71% | Upgrade
|
| Dividend Yield | 0.66% | 0.95% | 0.99% | 1.14% | 0.86% | 1.27% | Upgrade
|
| Payout Ratio | 95.09% | 73.15% | 44.53% | 26.83% | 39.27% | 55.01% | Upgrade
|
| Buyback Yield / Dilution | -1.31% | -0.15% | -0.82% | 0.42% | -5.03% | -0.70% | Upgrade
|
| Total Shareholder Return | -0.66% | 0.81% | 0.16% | 1.56% | -4.17% | 0.57% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.